首页> 外文期刊>Haemophilia: the official journal of the World Federation of Hemophilia >Pharmacokinetic profile of Optivate (R) (high-purity factor VIII/von Willebrand factor concentrate) in treating von Willebrand disease

【24h】

Pharmacokinetic profile of Optivate (R) (high-purity factor VIII/von Willebrand factor concentrate) in treating von Willebrand disease

机译：Optivate（R）（高纯度VIII因子/ von Willebrand因子浓缩物）在治疗von Willebrand疾病中的药代动力学

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Haemophilia: the official journal of the World Federation of Hemophilia》 |2016年第1期|共5页
作者
Shaikh-Zaidi R.; Lubetsky A.; Inbal A.; Dash C.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类妇产科学;
关键词

相似文献

外文文献
中文文献
专利

1. Pharmacokinetic profile of Optivate (R) (high-purity factor VIII/von Willebrand factor concentrate) in treating von Willebrand disease [J] . Shaikh-Zaidi R., Lubetsky A., Inbal A., Haemophilia: the official journal of the World Federation of Hemophilia . 2016,第1期

机译：Optivate（R）（高纯度VIII因子/ von Willebrand因子浓缩物）在治疗von Willebrand疾病中的药代动力学
2. Clinical assessment of Optivate(R), a high-purity concentrate of factor VIII with von Willebrand factor, in the management of patients with haemophilia A. [J] . Dmoszynska A, Kuliczkowski K, Hellmann A, Haemophilia: the official journal of the World Federation of Hemophilia . 2011,第3期

机译：Optivate（R）是一种高纯度的凝血因子VIII和von Willebrand因子的临床评估，用于治疗A型血友病。
3. Successful treatment of patients with von Willebrand disease using a high-purity double-virus inactivated factor VIII/von Willebrand factor concentrate (Immunate). [J] . Auerswald G, Eberspacher B, Engl W, Seminars in Thrombosis and Hemostasis . 2002,第2期

机译：使用高纯度双病毒灭活的VIII因子/ von Willebrand因子浓缩液（免疫）成功治疗von Willebrand病患者。
4. IMMUNATE S/D - A new Factor VIII - von-Willebrand Factor Complex Concentrate [C] . P.L. Turecek, W. Schonhofer, T.R. Kreil, Hemophilie-Symposion . 2004

机译：免疫S / D - 一种新因子VIII - von-Willebrand系数复合浓缩物
5. The effect of biomechanical and biochemical regulators on the expression of Factor VIII and von Willebrand Factor in endothelial cells [D] . Leonard, Jacqueline Marianna Morello. 2016

机译：生物力学和生化调节剂对内皮细胞中VIII因子和von Willebrand因子表达的影响
6. Prophylactic efficacy and pharmacokinetically guided dosing of a von Willebrand factor/factor VIII concentrate in adults and children with von Willebrands disease undergoing elective surgery: a pooled and comparative analysis of data from USA and European Union clinical trials [O] . Pier Mannuccio Mannucci, Paul Alexander Kyrle, Sam Schulman, 2013

机译：von Willebrand因子/因子VIII浓缩物在接受择期手术的成年人和儿童中的预防性功效和药代动力学指导的剂量：来自美国和欧盟临床试验的数据的汇总和比较分析
7. Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin (R)): a prospective study of 50 patients [O] . Borel-Derlon, A., Federici, A. B., Roussel-Robert, V., 2007

机译：用高纯度von Willebrand因子浓缩物治疗严重的von Willebrand病（Wilfactin（R））：50例患者的前瞻性研究

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号